Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
JelikaLite Announces Positive Results From a New Feasibility Study, Successful Raise of $760,000 and Acceptance into Mount Sinai Elementa Labs Program
Pilot study data suggests that JelikaLite’s Cognilum medical device reduces symptoms of autism in young children and improves the quality of life of their families.
Dymicron has partnered with DealMaker for its self-hosted $15.8 million raise. Regulation A+ raise. Regulation A+ is a relatively new exemption which allows private companies to sell their shares to unaccredited investors.
Miach Orthopaedics advises funds will enable ongoing operations and expand the U.S. commercial rollout of the BEAR Implant.
Ferronova CEO Stewart Bartlett said raising capital in a challenging environment and winning a CRC-P grant was a credit to the strength of Ferronova's technology.
Funding will support the company's rapid, full commercialization of its TEECAD® System. "These significant investments underscore the tremendous confidence in our state-of-the-art solution, experienced team, and the growth trajectory we are on to fully commercialize our TEECAD System," says Christine Horton, president and CEO of Visura.
Cardiac Dimensions reports financing was co-led by existing investor Horizon 3 Healthcare and an undisclosed strategic investor, with all other existing investors participating, including Arboretum Ventures, Hostplus, EQT Life Sciences (formerly LSP), Lumira Ventures, and M. H. Carnegie & Co.